90 related articles for article (PubMed ID: 9484505)
21. Mesoionic xanthine analogues: antagonists of adenosine receptors.
Glennon RA; Tejani-Butt SM; Padgett W; Daly JW
J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Pharmacological Evaluation of Identified and Putative Metabolites of the A
Holschbach MH; Bier D; Sihver W; Schulze A; Neumaier B
ChemMedChem; 2017 May; 12(10):770-784. PubMed ID: 28217962
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron emission tomography (PET).
Holschbach MH; Bier D; Stüsgen S; Wutz W; Sihver W; Coenen HH; Olsson RA
Eur J Med Chem; 2006 Jan; 41(1):7-15. PubMed ID: 16289482
[TBL] [Abstract][Full Text] [Related]
24. Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.
Hohoff C; Garibotto V; Elmenhorst D; Baffa A; Kroll T; Hoffmann A; Schwarte K; Zhang W; Arolt V; Deckert J; Bauer A
Neuropsychopharmacology; 2014 Dec; 39(13):2989-99. PubMed ID: 24943643
[TBL] [Abstract][Full Text] [Related]
25. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
26. A novel irreversible antagonist of the A1-adenosine receptor.
Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
[TBL] [Abstract][Full Text] [Related]
27. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
[TBL] [Abstract][Full Text] [Related]
28. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
29. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines.
Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A
Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist.
Ishiwata K; Noguchi J; Toyama H; Sakiyama Y; Koike N; Ishii S; Oda K; Endo K; Suzuki F; Senda M
Appl Radiat Isot; 1996; 47(5-6):507-11. PubMed ID: 8673072
[TBL] [Abstract][Full Text] [Related]
31. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
32. Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies.
Bennacef I; Tymciu S; Dhilly M; Mongin F; Quéguiner G; Lasne MC; Barré L; Perrio C
J Org Chem; 2004 Apr; 69(7):2622-5. PubMed ID: 15049675
[TBL] [Abstract][Full Text] [Related]
33. Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging.
Kopka K; Wagner S; Riemann B; Law MP; Puke C; Luthra SK; Pike VW; Wichter T; Schmitz W; Schober O; Schäfers M
Bioorg Med Chem; 2003 Aug; 11(16):3513-27. PubMed ID: 12878144
[TBL] [Abstract][Full Text] [Related]
34. 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion.
Bauer A; Langen KJ; Bidmon H; Holschbach MH; Weber S; Olsson RA; Coenen HH; Zilles K
J Nucl Med; 2005 Mar; 46(3):450-4. PubMed ID: 15750158
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of radioiodinated 8-Cyclopentyl-3-[(E)-3-iodoprop-2-en-1-yl]-1-propylxanthine ([*I]CPIPX) as a new potential A1 adenosine receptor antagonist for SPECT.
Sihver W; Holschbach MH; Bier D; Wutz W; Schulze A; Olsson RA; Coenen HH
Nucl Med Biol; 2003 Aug; 30(6):661-8. PubMed ID: 12900292
[TBL] [Abstract][Full Text] [Related]
36. Molecular simulation of 8-styrylxanthines.
Mager PP; Reinhardt R; Richter M; Walther H; Rockel B
Drug Des Discov; 1995 Nov; 13(2):89-107. PubMed ID: 8872454
[TBL] [Abstract][Full Text] [Related]
37. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
38. Influence of incubation conditions on microsomal metabolism of xanthine-derived A
Schneider D; Bier D; Bauer A; Neumaier B; Holschbach M
J Pharmacol Toxicol Methods; 2019; 95():16-26. PubMed ID: 30476620
[TBL] [Abstract][Full Text] [Related]
39. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists.
Schneller SW; Ibay AC; Christ WJ; Bruns RF
J Med Chem; 1989 Oct; 32(10):2247-54. PubMed ID: 2795597
[TBL] [Abstract][Full Text] [Related]
40. 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A
Humpert S; Schneider D; Bier D; Schulze A; Neumaier F; Neumaier B; Holschbach M
Eur J Med Chem; 2024 May; 271():116380. PubMed ID: 38615410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
